Patient Resources
Patient Support Programs
If you have pulmonary arterial hypertension (PAH), there are ways you can chart your health and stay informed about your condition: taking 6-minute walk tests (6MW), having your blood pressure monitored, and keeping track of how many nanograms (your dosage) of REMODULIN® (treprostinil sodium) Injection you are taking. Taking a proactive role in managing PAH is important.
Additionally, patients taking REMODULIN have a wide range of additional support resources available to them. United Therapeutics encourages all patients to take advantage of these programs whenever able, and to seek out as much information and assistance as possible in living with PAH.
PAP (Patient Assistance Program)
United Therapeutics created this program to provide access to REMODULIN medication and supplies for patients who cannot afford therapy because of their financial situations, those who do not have enough insurance or are between insurance plans, and those who have insurance restrictions.
Patient Assistance Program
For more information, please contact United Therapeutics at 1-888-485-8350.
PEER Network (Patients Exchanging Experiences with REMODULIN)
The PEER Network is a unique program that connects people who are considering taking REMODULIN or who have recently started therapy with experienced REMODULIN patients — called PEER Mentors. The PEER Network allows for the exchange of private phone calls and one-to-one e-mails through a secure Web-based system and also offers a supportive group speaker program.
www.peernetwork.net
RTA (REMODULIN Therapy Assistance)
Through RTA, every REMODULIN patient has the opportunity to build a relationship with a dedicated REMODULIN Therapy Assistant whose role is to offer nonmedical assistance in support of REMODULIN therapy. Assistance may include providing additional information about REMODULIN and answering general insurance questions.
REMODULIN Therapy Assistance
For more information, please contact United Therapeutics at or call 1-877-UNITHER.
For complete prescribing information, please refer to the REMODULIN package insert.
REMODULIN is a registered trademark of United Therapeutics Corporation.
